Keystone Symposium: Epigenetics and Human Disease (X5); March 17-21, 2019 in Banff, Alberta, Canada.
Sarah Attwell will be presenting a short talk on Tuesday March 19th titled "The BET Inhibitor ZEN-3694 Blocks Multiple Tumor Immune Suppressive Factors and has the Potential to Increase the Efficacy of Anti-PD1 Treatment"
Good luck! Do they drive or fly to Banff?
BDAZ